Evidence map›Paper›PMID 39896007›Full record

ArticlePeerJ. Computer science2025

Hybrid deep learning approach for brain tumor classification using EfficientNetB0 and novel quantum genetic algorithm.

Kerem Gencer, Gülcan Gencer

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kerem GencerAfyon Kocatepe University, Faculty of Engineering, Department of Computer Engineering, Afyonkarahisar, Turkey.
Gülcan GencerAfyonkarahisar Health Sciences University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, Afyonkarahisar, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most complex and life-threatening pathologies of the central nervous system is brain tumors. Correct diagnosis of these tumors plays an important role in determining the treatment plans of patients. Traditional classification methods often rely on manual assessments, which can be prone to error. Therefore, multiple classification of brain tumors has gained significant interest in recent years in both the medical and computer science fields. The use of artificial intelligence and machine learning, especially in the automatic classification of brain tumors, is increasing significantly. Deep learning models can achieve high accuracy when trained on datasets in diagnosis and classification. This study examined deep learning-based approaches for automatic multi-class classification of brain tumors, and a new approach combining deep learning and quantum genetic algorithms (QGA) was proposed. The powerful feature extraction ability of the pre-trained EfficientNetB0 was utilized and combined with this quantum genetic algorithms, a new approach was proposed. It is aimed to develop the feature selection method. With this hybrid method, high reliability and accuracy in brain tumor classification was achieved. The proposed model achieved high accuracy of 98.36% and 98.25%, respectively, with different data sets and significantly outperformed traditional methods. As a result, the proposed method offers a robust and scalable solution that will help classify brain tumors in early and accurate diagnosis and contribute to the field of medical imaging with patient outcomes.

Indexed as

Brain tumorConvolutional neural networkDeep learningMedical image analysisQuantum genetic algorithms

Identifiers

PMID39896007
PMCPMC11784816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.